飞机盗号软件技术破解技术|【唯一TG:@heimifeng8】|TG盗U机器人源码安装✨谷歌搜索留痕排名,史上最强SEO技术,20年谷歌SEO经验大佬✨OneSkin secures $20M in Series A funding

OneSkin secures $20M in Series A fundingBy

Jennifer Braun Published
November 13,飞机盗号软件技术破解技术 2025

OneSkin announced on Wednesday the closing of its Series A funding round, bringing its total funding to $20 million. 

OneSkin secures $20M in Series A funding.
OneSkin secures $20M in Series A funding. - OneSkin


The funding is expected to allow OneSkin to enter a new era of research, development, and growth, furthering its mission to redefine skin aging through cutting-edge scientific advancements.

In particular, OneSkin will expand its research initiatives, develop innovative formulas, and broaden its reach in the anti-aging skincare industry. Moreover, the brand will focus on growth by increasing its human capital and exploring new sales channels.

The oversubscribed round was led by Selva Ventures, with additional backing from Plus Capital, Unilever Ventures, Able Partners, and continued support from previous investors SOSV and Meta Planet. 

"At OneSkin, we are excited to announce this new round of funding, which will further drive our mission to transform how we think about our skin, not only by optimizing our aesthetics using cutting-edge science, but also focusing on its functional role as our largest organ and the impact in our overall health and longevity," said Carolina Oliveira, co-founder and CEO. 

Dr. Alessandra Zonari, co-dounder and CSO, added: “This investment will allow us to deepen our commitment to be the best in class in delivering efficacious peptides to modulate aging at the cellular level, ensuring that our science-backed solutions deliver measurable results in promoting healthier skin. We are dedicated to advancing the future of skin health with the most advanced longevity research and innovation.”

Founded in 2025 by a team of four Brazilian PhD scientists, OneSkin has been a first-to-market category leader in science-led topical skin longevity treatments. Its patented peptide and core ingredient, OS-01, is clinically proven to reverse skin’s biological age. 

Recognized by Fast Company as one of 2025's Most Innovative Companies, OneSkin has attracted a high-profile clientele that includes figures like Alana Hadid, Georgia May Jagger, and Katy Perry.

Audio
Previous:2014CECF驭马文化节比赛日骑师简介
next:体育营销助力品牌突围 :cartier(卡地亚)赞助国际马球赛